CMO
IBB icon

Covenant Multifamily Offices’s iShares Biotechnology ETF IBB Stock Holding History

Covenant Multifamily Offices’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-460
Closed -$51K – 189
2019
Q1 		$51K Buy
+460
New +$50.5K 0.02% 110

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Covenant Multifamily Offices's IBB Position: Q2 2019 in Review

Covenant Multifamily Offices sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 460 shares — an estimated $51K sold.

Covenant Multifamily Offices first reported a position in IBB in Q1 2019 and held it in 1 quarter. The position peaked at $51K in Q1 2019. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • Covenant Multifamily Offices reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • Covenant Multifamily Offices sold 460 iShares Biotechnology ETF shares in Q2 2019, an estimated $51K.
  • Covenant Multifamily Offices first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 1 quarter.
  • Covenant Multifamily Offices's iShares Biotechnology ETF position peaked at $51K in Q1 2019.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Covenant Multifamily Offices's 13F filing for Q2 2019, filed 31 Jul 2019.